Human Immunodeficiency Virus (HIV) Type 1 Reverse Transcriptase Resistance Mutations in Hepatitis B Virus (HBV)-HIV-Coinfected Patients Treated for HBV Chronic Infection Once Daily with 10 Milligrams of Adefovir Dipivoxil Combined with Lamivudine

Adefovir dipivoxil (ADV) at a suboptimal concentration for human immunodeficiency virus type 1 (HIV-1) (10 mg once daily) can be used to treat hepatitis B virus (HBV) infection in HIV-1-HBV-coinfected patients and does not, even in the case of uncontrolled HIV-1 replication, select for either ADV mu...

詳細記述

書誌詳細

出版年:	Antimicrob Agents Chemother
主要な著者:	Delaugerre, Constance, Marcelin, Anne-Geneviève, Thibault, Vincent, Peytavin, Gilles, Bombled, Tony, Bochet, Marie-Valérie, Katlama, Christine, Benhamou, Yves, Calvez, Vincent
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 2002
主題:	Antiviral Agents
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127167/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11959607/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.5.1586-1588.2002
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!